This Form 3 filing is routine and holds no actionable trading information. Monitor for subsequent insider trading activity (Form 4 filings) by HRT Financial LP, which could signal changes in conviction. Given CMND's small market cap (~$3M), any material insider buying or selling could disproportionately move the stock.
Price Chart
Executive Summary
HRT Financial LP filed a Form 3 initial statement of beneficial ownership of securities in Clearmind Medicine Inc. (CMND), disclosing ownership of 101,951 shares of common stock. As a routine insider holdings disclosure by an institutional LP, this filing is neutral for valuation and does not convey any material change in operations, financials, or strategy.
Key Facts
- Filing type: Form 3 (initial statement of beneficial ownership)
- Reporting owner: HRT Financial LP, a Delaware limited partnership
- Issuer: Clearmind Medicine Inc. (CMND), a pharmaceutical preparations company
- HRT Financial LP beneficially owns 101,951 shares of CMND common stock
- Date of event requiring statement: 2026-06-10
- Filed on 2026-06-12 with SEC
Financial Impact
No financial impact. The filing is a regulatory disclosure of existing beneficial ownership, not a transaction or event that changes the company's financials.
Risk Factors
- No material risks identified from this filing — it is purely a beneficial ownership disclosure
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001475597-26-000079 |
| Document: 0001475597-26-000079-index.html | 0001475597-26-000079 |
| Document: 0001475597-26-000079.txt | 0001475597-26-000079 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 6-K | $5.92 | awaiting T+60 | — | $5.95 (+0.47%) |
Oct 27, 2026 today | Press Release | $6.50 | awaiting T+60 | — | $5.95 (−8.50%) |
Oct 16, 2026 10d ago | 6-K | $6.00 | awaiting T+60 | — | $5.95 (+0.87%) |
Oct 13, 2026 14d ago | 6-K | $6.23 | awaiting T+60 | — | $5.95 (−4.53%) |
Oct 8, 2026 19d ago | 6-K | $6.60 | awaiting T+60 | — | $5.95 (−9.88%) |
Oct 7, 2026 20d ago | 6-K | $6.60 | awaiting T+60 | — | $5.95 (−9.88%) |
Sep 23, 2026 4w ago | 6-K | $0.8500 | awaiting T+60 | — | $5.95 (+599.72%) |
Sep 23, 2026 4w ago | Press Release | $0.8500 | awaiting T+60 | — | $5.95 (+599.72%) |
Sep 17, 2026 5w ago | Press Release | $6.86 | awaiting T+60 | — | $5.95 (−13.35%) |
Sep 14, 2026 6w ago | 6-K | $0.9440 | awaiting T+60 | — | $5.95 (+530.04%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers